Frontlight ResearchEarly access
Cystic fibrosis trials in Germany
7 of 12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis
- Where
- Berlin, Potsdam
- Age
- 18 years and over
- People
- 64 worldwide
- Run by
- SpliSense Ltd.
See details and how to joinNCT06429176 - Phase 2Not yet taking people in GermanyA Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
- Where
- Berlin, Cologne, Hanover
- Age
- 18 years to 80 years
- People
- 300 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07720375 · EU 2026-525524-18-00 - No phaseTaking peopleLong-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis
- Where
- Aachen, Lübeck, München
- Age
- 18 years and over
- People
- 468 worldwide
- Run by
- Physio-Assist
See details and how to joinNCT06487273 - Phase 2Not yet taking people in GermanyDose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
- Where
- Ahrensburg, Berlin, Dresden, Frankfurt am Main, Frankfurt Am Main, Jena, Luebeck, Mainz, Munich
- Age
- 18 years to 85 years
- People
- 180 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07048262 · EU 2024-518821-13-00 - Phase 2Taking peopleSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients with Cystic Fibrosis
- Where
- Berlin, Munich, Potsdam
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Splisense Ltd.
See details and how to join2024-511184-28-00 - Phase 2Not yet taking people in GermanySafety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis
- Where
- Berlin, Essen, Mainz, Munich, Potsdam
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- Vertex Pharmaceuticals Inc.
See details and how to join2025-523400-72-00 - Phase 3Taking peopleEvaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older
- Where
- Berlin, Essen, Hanover
- Age
- 1 year to 17 years
- People
- 174 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT05844449 · EU 2022-503081-74-00